B-type Natriuretic Peptide (BNP) Testing

BNP (or NT-proBNP) testing is covered as an adjunctive diagnostic tool to help establish, exclude, or differentiate congestive heart failure—particularly in patients with acute dyspnea or when other tests are equivocal—only when used together with clinical findings and standard diagnostic studies. BNP testing is not covered for standalone use, routine screening, serial monitoring or management-guided treatment of CHF, and use for ACS risk stratification is not covered because it has not been shown to alter patient management.

"BNP (or NT-proBNP) measurement is reasonable and necessary when used with medical history, physical exam, laboratory studies, and chest x-ray to diagnose or differentiate congestive heart failure i..."

Sign up to see full coverage criteria, indications, and limitations.